IA
ELOS

IFP Advisors’s Syneron Medical Ltd ELOS Stock Holding History

IFP Advisors’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,000
Closed -$22K – 4381
2017
Q2 		$22K Hold
2,000
– – ﹤0.01% 2544
2017
Q1 		$21K Hold
2,000
– – ﹤0.01% 2495
2016
Q4 		$17K Buy
+2,000
New +$15.7K ﹤0.01% 2592
2016
Q1 		– Sell
-293
Closed -$2K – 4057
2015
Q4 		$2K Buy
+293
New +$2.23K ﹤0.01% 3436

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

IFP Advisors's ELOS Position: Q3 2017 in Review

IFP Advisors sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 2,000 shares — an estimated $22K sold.

IFP Advisors first reported a position in ELOS in Q4 2015 and held it in 4 quarters. The position peaked at $22K in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • IFP Advisors reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • IFP Advisors sold 2,000 Syneron Medical Ltd shares in Q3 2017, an estimated $22K.
  • IFP Advisors first reported a position in Syneron Medical Ltd in Q4 2015 and held it in 4 quarters.
  • IFP Advisors's Syneron Medical Ltd position peaked at $22K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on IFP Advisors's 13F filing for Q3 2017, filed 30 Oct 2017.